Eric Ostertag
Director at Poseida Therapeutics, Inc. (PSTX) since July 2020
Eric Ostertag has filed 25 insider reports with the SEC since January 2021, as director at Poseida Therapeutics, Inc. (PSTX). Eric Ostertag made no open-market purchases or sales in the last 12 months. The latest filing, on February 3, 2023, reports shares withheld for taxes or exercise price at Poseida Therapeutics, Inc. (PSTX).
- Filings
- 25
- Companies
- 1
- Bought on market
- $500K
- Sold on market
- $7.95M
Companies where Eric Ostertag is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince July 2020 | 827,320 | $500K | $7.95M | $3.50 | Feb 3, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Feb 1, 2023PSTXSEC Form 4: Ostertag Eric covered exercise/tax liability with 11,776 shares, decreasing direct ownership by 1% to 827,320 units (tax withholding)Form 4Shares withheld for taxes or exercise price
- Jan 18, 2023PSTXSEC Form 5 filed by Ostertag EricForm 5
- Aug 8, 2022+$500KPSTXSEC Form 4: Ostertag Eric bought $500,000 worth of shares (142,857 units at $3.50), increasing direct ownership by 21% to 838,824 unitsForm 4Open-market purchase10b5-1 plan
- Aug 3, 2022-$593KPSTXSEC Form 4: Ostertag Eric sold $592,808 worth of shares (160,696 units at $3.69) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Feb 1, 2022PSTXSEC Form 4: Ostertag Eric was granted 89,500 shares and gifted 142,857 shares, decreasing direct ownership by 0.64% to 692,967 unitsForm 4Grant or awardGift
- Nov 19, 2021PSTXSEC Form 4: Ostertag Eric exercised 1,000 shares at a strike of $9.15, increasing direct ownership by 0.14% to 697,422 unitsForm 4Exercise or conversion of a derivative
- Nov 8, 2021-$134KPSTXSEC Form 4: Ostertag Eric sold $134,171 worth of shares (18,924 units at $7.09) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Oct 11, 2021PSTXSEC Form 4: Ostertag Eric exercised 18,525 shares at a strike of $9.15, increasing direct ownership by 3% to 696,422 unitsForm 4Exercise or conversion of a derivative
- Oct 1, 2021-$141KPSTXSEC Form 4: Ostertag Eric sold $140,604 worth of shares (20,029 units at $7.02) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Sep 20, 2021-$160KPSTXSEC Form 4: Ostertag Eric sold $160,020 worth of Common Stock (20,000 units at $8.00)Form 4Open-market sale10b5-1 plan
- Sep 14, 2021-$163KPSTXSEC Form 4: Ostertag Eric exercised 21,281 units of Common Stock at a strike of $8.12 and sold $162,712 worth of Common Stock (20,000 units at $8.14), increasing direct ownership by 3% to 675,415 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 2, 2021-$944KPSTXSEC Form 4: Ostertag Eric sold $943,646 worth of Common Stock (112,411 units at $8.39)Form 4Open-market sale10b5-1 plan
- Aug 6, 2021PSTXSEC Form 4: Ostertag Eric exercised 111,149 units of Common Stock at a strike of $9.15, increasing direct ownership by 20% to 654,134 unitsForm 4Exercise or conversion of a derivative
- Aug 3, 2021-$271KPSTXSEC Form 4: Ostertag Eric sold $270,970 worth of Common Stock (33,673 units at $8.05)Form 4Open-market sale10b5-1 plan
- Jul 2, 2021-$446KPSTXSEC Form 4: Ostertag Eric sold $446,174 worth of Common Stock (48,105 units at $9.28)Form 4Open-market sale10b5-1 plan
- Jun 2, 2021-$694KPSTXSEC Form 4: Ostertag Eric sold $694,302 worth of Common Stock (81,916 units at $8.48)Form 4Open-market sale10b5-1 plan
- May 4, 2021-$469KPSTXSEC Form 4: Ostertag Eric sold $468,839 worth of Common Stock (54,312 units at $8.63)Form 4Open-market sale10b5-1 plan
- Jul 9, 2020PSTXSEC Form 3 filed by Ostertag Eric (Amendment)Form 3New insider
- Apr 5, 2021-$1.1MPSTXSEC Form 4: Eric Ostertag sold $1,104,998 worth of Common Stock (115,000 units at $9.61)Form 4Open-market sale10b5-1 plan
- Mar 2, 2021-$1.33MPSTXSEC Form 4: Eric Ostertag sold $1,334,461 worth of Common Stock (115,000 units at $11.60)Form 4Open-market sale10b5-1 plan
- Feb 23, 2021PSTXSEC Form 4: Eric Ostertag exercised 111,395 units of Common Stock at a strike of $1.17, increasing ownership by 26% to 542,985 unitsForm 4Exercise or conversion of a derivative
- Feb 16, 2021-$1.33MPSTXSEC Form 4: Eric Ostertag sold $1,332,036 worth of Common Stock (133,149 units at $10.00)Form 4Open-market sale10b5-1 plan
- Feb 10, 2021-$124KPSTXSEC Form 4: Eric Ostertag exercised 67,534 units of Common Stock at a strike of $1.29 and sold $123,890 worth of Common Stock (12,389 units at $10.00), increasing ownership by 19% to 431,590 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 4, 2021PSTXSEC Form 4 filed by Eric OstertagForm 4Grant or award
- Jan 21, 2021-$44.6KPSTXSEC Form 4: Eric Ostertag sold $44,620 worth of Common Stock (4,462 units at $10.00)Form 4Open-market sale10b5-1 plan
Compare Eric Ostertag with
- Eric Ostertag vs Rafael Amado1 shared
- Eric Ostertag vs Luke Corning1 shared
- Eric Ostertag vs John P. Schmid1 shared
- Eric Ostertag vs Marcea Bland Lloyd1 shared
- Eric Ostertag vs Cynthia Collins1 shared
- Eric Ostertag vs Charles M Baum1 shared
Other insiders at the same companies
- Malin Life Sciences Holdings LtdPSTX
- Rafael AmadoPSTX
- Luke CorningPSTX
- John P. SchmidPSTX
- Marcea Bland LloydPSTX
- Cynthia CollinsPSTX
- Charles M BaumPSTX
- Johanna MyletPSTX
- Harry J LeonhardtPSTX
- Syed Ali-aamir RizviPSTX
- Mark J GergenPSTX
- Kristin YaremaPSTX
Questions about Eric Ostertag
- What is Eric Ostertag's role at Poseida Therapeutics, Inc.?
- Eric Ostertag reports to the SEC as director at Poseida Therapeutics, Inc. (PSTX), according to the latest filing on February 3, 2023.
- How many shares does Eric Ostertag own?
- After the latest filing that states it, Eric Ostertag directly owned 827,320 shares of Poseida Therapeutics, Inc. (PSTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Ostertag bought or sold stock recently?
- The most recent open-market purchase was on August 8, 2022: bought 142,857 shares of Poseida Therapeutics, Inc. (PSTX) for $500K at an average of $3.50. The most recent open-market sale was on August 3, 2022: sold 160,696 shares of Poseida Therapeutics, Inc. (PSTX) for $593K at an average of $3.69.
- How do I get alerts when Eric Ostertag files?
- Follow Eric Ostertag on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric Ostertag (SEC CIK 0001765987). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2021 on. View on SEC EDGAR · Get this as JSON